Development of ex-vivo culture for novel drug discovery in intravascular large B-cell lymphoma

Mika Takai

Presentation information

Oral Session

Oral Session 1-15A B Cell Lymphoma: Molecular Mechanism/Therapeutic Target

Fri. Oct 11, 2019 9:00 AM - 10:00 AM No.15 (Tokyo International Forum, 7F G701)

Chair: Koichi Sugimoto (Dept of Hematol/Oncol, JR Tokyo General Hospital, Tokyo, Japan)

[OS1-15A-4] Development of ex-vivo culture for novel drug discovery in intravascular large B-cell lymphoma

Mika Takai¹, Kazuyuki Shimada², Kazuhiko Hayashi¹, Yuuko Wada¹, Yuuki Kozakai¹, Takashi Watanabe¹, Takashi Suzuki¹, Kenji Yoshida¹, Tadaaki Ohtani¹, Hitoshi Kiyoi² (1.Fujii Memorial Research Institute, Otsuka Pherma. Co., Ltd., Shiga, Japan, 2.Hematol. and Oncol., Nagoya Univ., Aichi, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.